🚀 DOCN $1.6M ITM Call Blitz — Big Money Bets DigitalOcean's AI Ramp Keeps Running!

📅 June 26, 2026 | 🔥 Unusual Activity Detected

✅ Updated June 29, 2026 (morning OI check): Next-day OPRA OI ROSE 20 → 1,520 (Δ +1,500), confirming this as an opening BTO. The read below holds — no inversion. See the ✅ RESOLVED box.

🎯 The Quick Take

Someone just dropped $1.6 MILLION on short-dated DigitalOcean call options with only 6 days to go! This isn't your casual day-trader play — a single buyer swept up 1,350 contracts of the July 2 $130 calls at $12.16, already in-the-money with DOCN trading at $138.05. Translation for regular folks: this is a leveraged bet that DigitalOcean keeps running higher this week — loaded up with borrowed momentum on the back of an AI ARR that just grew 221% YoY.

📊 Company Overview

DigitalOcean (NYSE: DOCN) is the cloud platform that AWS, Azure, and GCP forgot — built for startups, small businesses, and individual developers who want powerful cloud tools without the enterprise price tag or complexity.

Market Cap: ≈$14.6 billion (stockanalysis.com)
TTM Revenue: $948.6M | TTM Net Income: $236.8M
Industry: Cloud Infrastructure / Software-Infrastructure Technology
Core products: Droplets (compute VMs), managed databases, storage, Kubernetes — and increasingly GPU Droplets + GenAI / Gradient platform (powered by NVIDIA H100s) for AI inference, managed agents, and vector-database workloads via its Paperspace acquisition
The AI angle: DOCN is democratizing AI for the SMB and developer crowd — letting startups and small teams run H100 workloads and GenAI apps that were previously only affordable to the hyperscalers (VentureBeat)

52-week range: $25.56 – $187.50 — yes, that's a 7x move off the 52-week low. The stock re-rated violently in 2026 as the AI business inflected, ran to $187 in May, and has since pulled back to ≈$138 — down >20% from that peak. That's the setup for today's bet.

💰 The Option Flow Breakdown

📊 What Just Happened

Here's exactly what hit the tape at 11:58:51 ET today:

Time	Buy/Sell	Call/Put	Expiration	Premium	Strike	Volume	OI	Size	Spot	Option Price	Flow Type
11:58:51	BUY	CALL	2026-07-02	$1.6M	$130	1,500	20	1,350	$138.05	$12.16	⚡ LIT

Symbol: DOCN20260702C130

Key facts from the tape:

⚡ Execution: LIT — this hit the displayed book on an exchange, not a negotiated block. Real buying pressure, not a dealer-to-dealer handoff.
💵 Net premium paid: $1.6M (1,350 contracts × 100 shares × $12.16) — this is CASH SPENT, fully at risk.
📍 In-the-money: The $130 strike sits $8.05 below the $138.05 spot — this call already has intrinsic value; the buyer isn't waiting for the stock to climb.
⏰ 6 DTE: Expires July 2, 2026 — six trading days. Ultra-short fuse.
🏦 No equity block: Zero simultaneous stock trade on the tape — this is a pure options-only directional bet, not a delta-hedged package.

✅ RESOLVED — Next-Day OPRA OI Confirms an OPENING BUY (BTO)

The June 29 pre-market OPRA snapshot (reflecting June 26 end-of-day) is in. Open interest ROSE — confirming this as a fresh opening buy, not a close.

Leg Baseline OI (pre-print) Resolving OI (next-day) Δ Trade Size Verdict
$130 call exp 2026-07-02 (BUY) 20 1,520 +1,500 1,350 ✅ OPEN (BTO)

OI rose by +1,500 vs the 1,350-contract print, confirming a fresh opening buy (BTO long calls — the leveraged-long momentum bet). The conviction read below holds — no inversion.

🤓 What This Actually Means — Plain English

Let me break this down for you:

This is a leveraged-long momentum bet, not a hedge.

When someone buys an in-the-money call — meaning the strike ($130) is already below the current stock price ($138.05) — they're getting a call option that already has real value baked in. The $12.16 price they paid includes:

≈$8.05 of "intrinsic value" (the amount it's already in-the-money)
≈$4.11 of "time value" (the premium for 6 days of potential upside)

Think of it like this: instead of buying 135,000 shares of DOCN at $138.05 (which would cost ≈$18.6 million), this trader spent only $1.6 million to control that same exposure. If DOCN moves up $5 by July 2, this call position gains nearly as much as 135,000 shares would — but they risked 90% less capital to do it.

Why short-dated and in-the-money?

📈 High delta: ITM calls move nearly dollar-for-dollar with the stock — maximum leverage, minimum time-value decay relative to OTM plays.
⚡ Urgency signal: A 6-DTE bet is not a "let me wait and see" trade. This is "I think DOCN moves higher THIS week."
🤔 No scheduled catalyst before expiry: Q2 2026 earnings are on August 12, 2026 — well after July 2. There's no announced product event or conference this week. So this is a momentum and narrative trade, not an event-gamma bet.

What's the thesis? DOCN just reported AI ARR of $170M, up 221% YoY in Q1 2026, plus a guide to 50%+ revenue growth in 2027. Six analysts raised targets to $175–$200 post-Q1. The stock went from $25 to $187 and has now pulled back >20% to ≈$138. This buyer thinks the dip is overdone and is making a concentrated, short-duration bet that DOCN catches a bid this week.

Order type: BTO (Buy to Open) — new long call position, fully confirmed by size vs. OI.

📈 Technical Setup / Chart Check-Up

YTD Performance

DOCN YTD

DOCN's 2026 has been a full-on re-rating story. The stock spent Q4 2025 and early 2026 in the $25–$50 range before the AI ARR inflection lit the fuse. By late May 2026, it had ripped to a 52-week high of $187.50 — more than a 7x move off the lows.

Then reality checked in. From the mid-June peak of $174.18 (June 17), DOCN has pulled back sharply:

📉 $174.18 (June 17) → ≈$138.05 (June 26 trade time) — a >20% drawdown in nine days
📊 Volume on the pullback suggests a rotation out of momentum names, not a fundamental breakdown
⚠️ High realized volatility: a stock that moves 20% in a week cuts both ways for a short-dated call buyer

The trade today is essentially a bet that the pullback is a buying opportunity in an AI momentum name — not the start of a trend reversal.

Gamma-Based Support & Resistance Analysis

DOCN Gamma S/R

Reading the gamma exposure map from today's data (current reference price ≈$140.64):

🔵 Support Levels (Put Gamma = market-maker buying cushion below price):

$140 — immediate floor; meaningful put gamma concentration right at spot (total GEX 0.258). Market makers are long put gamma here → they buy stock on dips to hedge, creating a cushion.
$135 — strong put gamma wall (total GEX 0.359); the biggest put-side level near the current price. If DOCN dips here, expect mechanical support buying from dealers.
$130 — the trade's own strike (total GEX 0.153); also a put-gamma support. Meaningful, but lighter than $135.
$120 / $115 / $110 — deeper support levels with material put gamma stacking up through $110; the options market has built a put-heavy floor structure below ≈$130.

🟠 Resistance Levels (Call Gamma = market-maker selling pressure above price):

$145 — nearest resistance with the HEAVIEST total gamma of any strike (GEX 0.802, dominated by put gamma but the sheer weight of activity here creates friction). This is the near-term ceiling to watch.
$146 — call-gamma inflection (call GEX 0.173 > put GEX); small but meaningful call-side weight just above $145.
$149–$150 — the DOMINANT resistance zone. The $150 strike carries the single largest total gamma exposure in the whole chain (0.982 total GEX, call_gex 0.673). 🚧 This is the wall. Market makers are short a lot of call gamma at $150, meaning they'll sell stock to hedge as price approaches — creating natural ceiling pressure.
$155 / $160 / $175 / $180 — upper-level resistance sequence if $150 breaks; $160 (GEX 0.566) and $175 (GEX 0.349) and $180 (GEX 0.460) mark the staircase of supply above.

What this tells us: DOCN is currently sandwiched between $135 support (strong) and $150 resistance (the big wall). For the July 2 $130 call to be meaningfully profitable, DOCN needs to push toward and ideally through $150. The gamma structure says that's the key level — clear $150 and the ceiling opens toward $155-$160+.

Implied Move Analysis

DOCN Implied Move

The implied move cone visualizes what options traders are pricing as the expected range for DOCN through upcoming expirations. Given DOCN's elevated realized volatility (the stock moved >20% in nine days), the options market is pricing a wide cone.

Key implied move context:

The July 2 expiry (this trade's expiry, 6 DTE) implies a roughly ±4–6% potential range from spot — call it a ≈$132–$145 expected range around the $138 spot. The $130 strike is within the lower tail of that cone, meaning the call stays in-the-money unless DOCN drops ≈6%+ this week.
Q2 2026 earnings on August 12 (further out) show a much wider implied move — earnings are the next major vol event, and the market is pricing in a significant move. But that's after this option expires.
Analyst consensus target of $178.77 (11 buys, 0 sells per stockanalysis.com) represents ≈+28% upside from current levels — well above the near-term implied move window for this 6-DTE trade.

The math for this trade: For the July 2 $130 call to break even at expiry, DOCN needs to close above $130 + $12.16 = $142.16. At $138.05 today, that's about a +3% move needed by Wednesday July 2. The option is already deeply in-the-money — the buyer is not asking for a miracle; they need ≈$4 of additional upside over 6 days.

🎪 Catalysts

🔥 Recent Catalysts (Already Happened — the fuel for this trade)

Q1 2026 Earnings — The Re-Rating Catalyst:

DigitalOcean's Q1 2026 results crushed estimates and triggered the big re-rating:

📊 Revenue: $258M, +22% YoY
💰 EPS: $0.44 vs $0.26 consensus — a massive beat
🤖 AI ARR: $170M, +221% YoY — the headline that moved markets
🏢 $1M+ customer ARR: $183M, +179% YoY — enterprise traction is accelerating
📈 Adjusted EBITDA: $105M, +21% YoY

Management guidance raised to:

FY2026: ≈25–27% revenue growth, exit rate approaching ≈30%
FY2027: 50%+ revenue growth, ≈40% EBITDA margin — the number the bull thesis lives on (transcript)

Analyst target hikes post-Q1 (the consensus upgrade wave):

🏦 BofA → $200 (from $107) | Canaccord → $200 (from $120)
🏦 Oppenheimer → $190 (from $115) | Barclays → $183 (from $105)
🏦 Citi → $180 (from $115) | Morgan Stanley → $175 (from $75)

Strategic developments:

Launched DigitalOcean AI-native cloud — full-stack platform for inference and agentic workloads
Raised $888M in equity to fund expansion (transcript)
Secured ≈60 MW incremental data-center capacity, bringing total to ≈135 MW committed — the physical backbone powering AI ARR growth (DigitalOcean GPU/GenAI solutions)

📅 Upcoming Catalysts (What's Ahead)

Q2 2026 Earnings — August 12, 2026 (Before Market Open):

The next hard, dated catalyst is confirmed for August 12, 2026 — well after the July 2 option expiry. The market will be watching:

Does AI ARR hold the 221% trajectory? Even a deceleration to 150% would be reassuring; a miss below 100% growth would be painful at ≈124x forward P/E.
Does management nudge FY2026 guidance toward the high end, confirming the ≈30% exit-rate trajectory?
How fast is the 135 MW committed capacity filling with paying GPU/GenAI customers?

CRITICAL NOTE for this trade: The July 2 $130 call expires 41 days before Q2 earnings. There is NO scheduled DOCN catalyst (earnings, conference, product launch) inside the next 6 days. This buyer is riding momentum and narrative — not betting on a specific event. That's a higher-risk posture than an earnings-gamma bet.

Ongoing AI product ramp: The 135 MW of committed GPU capacity feeding AI ARR through H2 2026, plus the new inference-engine and managed-agents platform (GPU/GenAI roadmap), represents the ongoing revenue driver. New enterprise wins or product announcements could be the undated catalyst this buyer is anticipating.

Valuation context: At ≈124x forward P/E (stockanalysis.com), DOCN is priced for flawless execution. The pullback from $187.50 to ≈$138 has taken some froth off — but this is still a high-multiple, high-expectation growth stock, not a deep-value play.

🎲 Price Targets & Probabilities (Through July 2 Expiry)

Using gamma levels and implied move data, here's how the next 6 days might play out:

📈 Bull Case (≈30% probability) — Target: $148–$155

How we get there:

🚀 Momentum resumes post-pullback; AI narrative remains hot and buyers step back in
📊 Gamma structure: clear $145 friction → push toward the $150 gamma wall
💰 At $148 at expiry: call worth $18, profit ≈+$8 per contract ($8 × 1,350 × 100 = $1.08M gain, ≈+48% ROI)
🎯 At $155: call worth $25, profit ≈+$12.84 per contract ($12.84 × 1,350 × 100 = $1.73M gain, ≈+108% ROI)
📈 Breakout above $150 resistance would be technically significant — opens path to $155-$160+

What's needed: Positive broader tape, no adverse DOCN news, continued AI-sector enthusiasm.

🎯 Base Case (≈45% probability) — Target: $140–$148 range

Most likely scenario:

📊 DOCN muddles along near current levels, grinding toward $142–$145 resistance
⚖️ Breakeven for this call is $142.16 at expiry — the buyer needs just a ≈+3% move to get back to even
💰 At $142 at expiry: call worth ≈$12, roughly breakeven
🔄 The gamma weight at $145–$150 creates a ceiling that caps near-term upside without fresh catalysts
😐 DOCN stays in the $138–$148 chop zone for the week; call expires with modest profit or small loss

📉 Bear Case (≈25% probability) — $130 or below by July 2

What could go wrong:

😰 Continued tech/momentum selloff drags DOCN toward $130 gamma support
🚨 DOCN falls below $130 → call expires worthless → full $1.6M loss for the buyer
⚠️ A broader risk-off move hits high-multiple software hardest; DOCN's 124x forward P/E leaves no cushion
📉 At $128 at expiry: call worthless → buyer loses entire $1.6M premium (100% loss)

💡 Trading Ideas

🛡️ Conservative: Watch and Wait — Let the Gamma Story Develop

The play: Don't chase a 6-DTE ITM call right now. The option is already expensive (>$12 with only 6 days left) and a 6-day window with no scheduled catalyst is a narrow runway.

Why this works:

⏰ High-multiple growth stocks like DOCN can reverse hard; chasing a stock that already dropped 20%+ carries mean-reversion risk in BOTH directions
💸 Options are elevated — IV is high because the stock moves so much. You'd be paying up.
🎯 Better setup: wait for Monday's OI confirmation, see if DOCN holds $135 support, and look at longer-dated calls (August or later) that capture the Q2 earnings catalyst on August 12.
✅ If bullish on the AI story, consider buying DOCN shares on the pullback rather than ultra-short-dated options — stock at $138 is ≈27% below the consensus analyst target of $178.77

Risk level: Minimal (cash/long stock only) | Skill level: Beginner-friendly

⚖️ Balanced: August Call Spread — Ride the AI Story to Earnings

The play: If you're bullish on DOCN's AI-ARR momentum, position for the Q2 earnings catalyst on August 12 rather than a 6-DTE sprint.

Structure idea: Buy DOCN August 2026 $140 call / Sell August 2026 $160 call (a bull call spread)

Why this works:

📅 Captures the August 12 Q2 earnings report — the next real catalyst with potential for another AI-ARR beat
🛡️ The spread caps your max loss to the net debit vs. unlimited risk of a naked call
📊 The $150 gamma wall is the key level; if DOCN clears that post-earnings, the spread pays near full value toward $160
💰 Rough estimated cost: $7–$10 net debit depending on IV at entry; max gain at $160+ ≈$10–$13 per spread (100-130% ROI)
🎯 Breakeven: ≈$147–$150 at August expiry — a level the stock has recently traded

What to watch: Enter only after today's close or Monday open when you can gauge momentum direction. Set a stop if DOCN breaks below $130 ($135 gamma support acts as early warning).

Risk level: Moderate (defined risk) | Skill level: Intermediate

🚀 Aggressive: Replicate the Whale — Short-Dated ITM Call (Advanced Only!)

The play: Mirror the trade — buy DOCN July 2 $130 calls or similar short-dated ITM calls.

Why it could work:

🏃 Maximum delta exposure with limited capital vs. buying stock outright
📈 Breakeven at $142.16 is only ≈3% above current levels — a modest move pays off
⚡ If DOCN pops toward $145–$150 this week (gamma resistance zone), this call triples in value

Why it could blow up (SERIOUS RISKS!):

💀 Zero time to recover: 6 DTE means every day of flat or negative price action destroys premium rapidly. Theta decay is brutal on ITM short-dated options.
💸 $12.16 per contract: You're paying up front — if DOCN drifts sideways all week, you lose big even if the stock doesn't fall.
🎢 No catalyst: The buyer today may have information or conviction we don't. Copying a trade without knowing WHY is dangerous.
📉 DOCN fell 20%+ in 9 days recently — it can do it again. Below $130 = total wipeout on this position.
⚠️ This is a SPECULATION, not an investment. Suitable only for money you can afford to lose completely.

P&L at expiry (July 2):

Stock at $145: profit ≈ +$2.84/contract (+23%)
Stock at $150: profit ≈ +$7.84/contract (+64%)
Stock at $142: profit ≈ +$0 (breakeven)
Stock at $135: loss ≈ -$7.16/contract (-59%)
Stock at $130 or below: loss = -$12.16/contract (-100%)

Risk level: EXTREME | Skill level: Advanced only — only risk capital you can afford to lose entirely.

👥 For Different Types of Traders

🎰 YOLO Trader

This is your kind of trade — short-dated, ITM, maximum leverage. If DOCN runs $5–$10 this week, you're looking at 50-100%+ gains on a call position like this. But respect the risk: one bad session and you lose it all. Set a stop-loss on the stock price (e.g., below $133) rather than watching the option decay in real-time.

📅 Swing Trader

Skip the July 2 calls entirely — the time window is too narrow for swing-trading logic. Instead, look at the August 2026 calls (with Q2 earnings as the catalyst) or consider a bull call spread as described above. The DOCN AI story is real; give it room to breathe. Target the $150 gamma wall as a near-term resistance to clear before adding conviction.

💼 Premium Collector

This trade is the opposite of your playbook — the buyer is paying premium, not selling it. However, the high IV environment (DOCN moves 20%+ in 9 days) creates opportunities: consider selling cash-secured puts at the $130 strike (strong gamma support) or even $125/$120, collecting elevated premiums while targeting entry into DOCN stock at better levels. The 124x forward P/E and momentum profile mean premium-selling here carries meaningful assignment risk if AI sentiment sours.

🌱 Entry-Level Investor (Just Getting Started with Options)

Here's the plain-English version of what happened: someone paid $1.6 million for the right to buy 135,000 shares of DOCN at $130 — even though the stock is already at $138. They did this because they think the stock will be even higher in 6 days, and using options gave them much more leverage than buying stock directly. The risk is that if DOCN stays flat or drops, they lose the entire $1.6M. For you as a beginner: do not try to replicate this trade. Watch it as a learning example of how short-dated ITM calls work. If you want exposure to the DOCN AI story, start with a small stock position or a longer-dated option with 60+ days to expiry.

⚠️ Risk Factors

Don't let the excitement cloud your judgment. Here's what could go wrong:

⏰ No catalyst in the 6-day window: Q2 earnings aren't until August 12. There's no scheduled event that could create the gap move typically needed to make a short-dated option a home run. Momentum can reverse without warning.
💸 Valuation stretched at ≈124x forward P/E: stockanalysis.com shows DOCN's forward P/E is nearly double the trailing P/E — meaning the market is pricing in massive future earnings growth that hasn't happened yet. Miss the growth, lose the multiple.
📉 The pullback is already significant — but not complete: DOCN fell from $174 (June 17) to $138 (June 26) in nine days. High-momentum stocks can overshoot to the downside; a move to $125–$130 would not be shocking given recent volatility, and that would wipe out this call.
🏗️ Capex / dilution risk: The $888M equity raise funds 135 MW of data-center capacity. Heavy GPU capex carries execution and utilization risk; if AI ARR growth slows, the market will re-price those sunk costs harshly.
⚔️ Competitive pressure: CoreWeave, Lambda, Vultr, and the hyperscalers are all competing for the same SMB and developer AI spend. DOCN's pricing power isn't guaranteed (Northflank comparison).
📊 High realized volatility cuts both ways: This stock moves 3–5% on good days and 10%+ on bad ones. The same volatility that makes a 6-DTE ITM call exciting is what makes it lethal if the direction is wrong.
🔒 What the tape cannot tell us: We know SIZE and MECHANISM from the OPRA print — lit execution, fresh open, options-only. We do NOT know who bought it, what portfolio it's part of, or whether they have proprietary information. This could be a hedge for a short position, a speculative punt, or something else entirely. The tape tells us what was bought, not why.

🎯 The Bottom Line

Real talk: Someone put $1.6M on DigitalOcean's AI story continuing to play out — in 6 days, no catalyst, no safety net. That's conviction. Or it's calculated leverage from someone who knows DOCN well and thinks the pullback from $174 to $138 is overdone.

The fundamentals are genuinely strong: AI ARR +221% YoY to $170M, FY2027 guide of 50%+ growth, six analyst upgrades to $175–$200, 135 MW of committed GPU capacity coming online. The stock has the bones of a real AI re-rating story.

But the valuation (≈124x forward P/E), the absence of a near-term catalyst, and the extreme recent volatility (>20% drawdown in 9 days) make this a high-conviction, high-risk bet — not a high-probability one.

Three scenarios:

✅ If you're bullish on DOCN: Use longer-dated options (August+) or stock to position for the August 12 Q2 earnings catalyst with more time on your side. Don't chase a 6-DTE call after it's already been bought.
👀 If you're watching: Mark August 12, 2026 on your calendar — that's when the next hard read on AI ARR trajectory hits. If DOCN holds the $135 gamma support this week and consolidates, that's a better setup for a Q2 earnings play.
🐻 If you're skeptical: The 124x forward P/E with no near-term catalyst is a reasonable concern. The ≈$130 gamma support and ≈$135 put-gamma wall are the floor to watch; a sustained break there changes the picture.

Remember: Options are not stocks. A 3% move against you in DOCN at a 6-DTE ITM call can take 50% off the option's value. Manage your size accordingly.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and is not financial advice. Past performance does not guarantee future results. The unusual activity described reflects a single institutional trade — it does not imply the position will be profitable or that you should follow it. Buying short-dated in-the-money call options carries the risk of total loss of premium if the underlying stock does not move in the expected direction by expiry. Always conduct your own research and consult a licensed financial advisor before making any investment decisions. DigitalOcean's forward P/E of ≈124x reflects high growth expectations; any deceleration in AI ARR growth could result in significant price declines.

Last updated: June 29, 2026 — morning OI check confirmed an opening BTO: OI 20 → 1,520 (Δ +1,500). No inversion.

DOCN Unusual Options Activity — 2026-06-26

Institutional flow on 2026-06-26

Trade Details

Full Analysis